Fatigue and health-related quality of life in patients with immune thrombocytopenia: a longitudinal assessment in China

References

• Audia S, Mahévas M, Samson M, et al. Pathogenesis of immune thrombocytopenia. Autoimmun Rev. 2017 Jun;16(6):620–632. doi: 10.1016/j.autrev.2017.04.012
   PubMed Web of Science ®Google Scholar
• Liu XG, Bai XC, Chen FP, et al. Chinese guidelines for treatment of adult primary immune thrombocytopenia. Int J Hematol. 2018 Jun;107(6):615–623. doi: 10.1007/s12185-018-2445-z
   PubMed Web of Science ®Google Scholar
• Danese MD, Lindquist K, Gleeson M, et al. Cost and mortality associated with hospitalizations in patients with immune thrombocytopenic purpura. Am J Hematol. 2009 Oct;84(10):631–635. doi: 10.1002/ajh.21500
   PubMed Web of Science ®Google Scholar
• Provan D, Arnold DM, Bussel JB, et al. Updated international consensus report on the investigation and management of primary immune thrombocytopenia. Blood Adv. 2019 Nov 26;3(22):3780–3817. doi: 10.1182/bloodadvances.2019000812
   PubMed Web of Science ®Google Scholar
• Sestøl HG, Trangbæk SM, Bussel JB, et al. Health-related quality of life in adult primary immune thrombocytopenia [meta]. Expert Rev Hematol. 2018 Dec;11(12):975–985. doi: 10.1080/17474086.2018.1548930
   PubMed Web of Science ®Google Scholar
• Neunert C, Terrell DR, Arnold DM, et al. American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Adv. 2019 Dec 10;3(23):3829–3866. doi: 10.1182/bloodadvances.2019000966
   PubMed Web of Science ®Google Scholar
• McMillan R, Bussel JB, George JN, et al. Self-reported health-related quality of life in adults with chronic immune thrombocytopenic purpura. Am J Hematol. 2008 Feb;83(2):150–154. doi: 10.1002/ajh.20992
   PubMed Web of Science ®Google Scholar
• Zhou Z, Yang L, Chen Z, et al. Health-related quality of life measured by the short form 36 in immune thrombocytopenic purpura: a cross-sectional survey in China. Eur J Haematol. 2007 Jun;78(6):518–523. doi: 10.1111/j.1600-0609.2007.00844.x
   PubMed Web of Science ®Google Scholar
• Efficace F, Mandelli F, Fazi P, et al. Health-related quality of life and burden of fatigue in patients with primary immune thrombocytopenia by phase of disease. Am J Hematol. 2016 Oct;91(10):995–1001. doi: 10.1002/ajh.24463
   PubMed Web of Science ®Google Scholar
• Hill QA, Newland AC. Fatigue in immune thrombocytopenia. Br J Haematol. 2015 Jul;170(2):141–149. doi: 10.1111/bjh.13385
   PubMed Web of Science ®Google Scholar
• Newton JL, Reese JA, Watson SI, et al. Fatigue in adult patients with primary immune thrombocytopenia. Eur J Haematol. 2011;86(5):420–429. doi: 10.1111/j.1600-0609.2011.01587.x
   PubMed Web of Science ®Google Scholar
• Yang R, Yao H, Lin L, et al. Health-related quality of life and burden of fatigue in Chinese patients with immune thrombocytopenia: a cross-sectional study. Indian J Hematol Blood Transfus. 2020 Jan;36(1):104–111. doi: 10.1007/s12288-019-01124-7
   PubMed Web of Science ®Google Scholar
• Zhang H, Wang L, Quan M, et al. Health-related quality of life in children with chronic immune thrombocytopenia in China. Health Qual Life Outcomes. 2016 Mar 15;14(1):45. doi: 10.1186/s12955-016-0445-3
   PubMedGoogle Scholar
• https://www.chinablood.com.cn/jyb/hospitals.html
   Google Scholar
• Kochhar M, Neunert C. Immune thrombocytopenia: a review of upfront treatment strategies. Blood Rev. 2021 Sep;49:100822. doi: 10.1016/j.blre.2021.100822
   PubMed Web of Science ®Google Scholar
• Yellen SB, Cella DF, Webster K, et al. Measuring fatigue and other anemia-related symptoms with the Functional Assessment of cancer therapy (FACT) measurement system. J Pain Symptom Manage. 1997 Feb;13(2):63–74. doi: 10.1016/S0885-3924(96)00274-6
   PubMed Web of Science ®Google Scholar
• Webster K, Cella D, Yost K. The Functional Assessment of chronic Illness therapy (FACIT) measurement System: properties, applications, and interpretation. Health Qual Life Outcomes. 2003 Dec 16;1(1):79. doi: 10.1186/1477-7525-1-79
   PubMedGoogle Scholar
• Signorovitch J, Brainsky A, Grotzinger KM. Validation of the FACIT-fatigue subscale, selected items from FACT-thrombocytopenia, and the SF-36v2 in patients with chronic immune thrombocytopenia. Qual Life Res. 2011 Dec;20(10):1737–1744. doi: 10.1007/s11136-011-9912-9
   PubMed Web of Science ®Google Scholar
• Mathias SD, Bussel JB, George JN, et al. A disease-specific measure of health-related quality of life for use in adults with immune thrombocytopenic purpura: its development and validation. Health Qual Life Outcomes. 2007 Feb 22;5(1):11. doi: 10.1186/1477-7525-5-11
   PubMedGoogle Scholar
• Snyder CF, Mathias SD, Cella D, et al. Health-related quality of life of immune thrombocytopenic purpura patients: results from a web-based survey. Curr Med Res Opin. 2008 Oct;24(10):2767–2776. doi: 10.1185/03007990802377461
   PubMed Web of Science ®Google Scholar
• Mathias SD, Bussel JB, George JN, et al. A disease-specific measure of health-related quality of life in adults with chronic immune thrombocytopenic purpura: psychometric testing in an open-label clinical trial. Clin Ther. 2007 May;29(5):950–962. doi: 10.1016/j.clinthera.2007.05.005
   PubMed Web of Science ®Google Scholar
• Fogarty PF, Tarantino MD, Brainsky A, et al. Selective validation of the WHO bleeding scale in patients with chronic immune thrombocytopenia. Curr Med Res Opin. 2012 Jan;28(1):79–87. doi: 10.1185/03007995.2011.644849
   PubMed Web of Science ®Google Scholar
• De Livera AM, Zaloumis S, Simpson JA. Models for the analysis of repeated continuous outcome measures in clinical trials. Respirology. 2014 Feb;19(2):155–161. doi: 10.1111/resp.12217
   PubMed Web of Science ®Google Scholar
• Wong RSM, Yavaşoğlu İ, Yassin MA, et al. Eltrombopag in patients with chronic immune thrombocytopenia in Asia-Pacific, Middle East, and Turkey: final analysis of CITE. Blood Adv. 2022;7(17):4773–4781. doi: 10.1182/bloodadvances.2022008287
   Web of Science ®Google Scholar
• Grace RF, Klaassen RJ, Shimano KA, et al. Fatigue in children and adolescents with immune thrombocytopenia. Br J Haematol. 2020 Jun 5;191(1):98–106. doi: 10.1111/bjh.16751
   PubMed Web of Science ®Google Scholar
• Mitchell E, Frith J, Newton J. Fatigue and cognitive impairment in immune thrombocytopenic purpura remain stable over time: short report from a longitudinal study. Br J Haematol. 2019 Sep;186(5):777–781. doi: 10.1111/bjh.15993
   PubMed Web of Science ®Google Scholar
• Zhou H, Qin P, Liu Q, et al. A prospective, multicenter study of low dose decitabine in adult patients with refractory immune thrombocytopenia. Am J Hematol. 2019 Dec;94(12):1374–1381. doi: 10.1002/ajh.25646
   PubMed Web of Science ®Google Scholar
• Flores A, Klaassen RJ, Buchanan GR, et al. Patterns and influences in health-related quality of life in children with immune thrombocytopenia: a study from the Dallas ITP cohort. Pediatr Blood Cancer. 2017 Aug;64(8). doi: 10.1002/pbc.26405
   Web of Science ®Google Scholar
• Huang HP, Chen ML, Liang J, et al. Changes in and predictors of severity of fatigue in women with breast cancer: a longitudinal study. Int J Nurs Stud. 2014 Apr;51(4):582–592. doi: 10.1016/j.ijnurstu.2013.09.003
   PubMed Web of Science ®Google Scholar
• Farruggia P, Fioredda F, Puccio G, et al. Idiopathic neutropenia of infancy: data from the Italian neutropenia registry. Am J Hematol. 2019 Feb;94(2):216–222. doi: 10.1002/ajh.25353
   PubMed Web of Science ®Google Scholar
• Giordano P, Lassandro G, Valente M, et al. Current management of the hemophilic child: a demanding interlocutor. Quality of life and adequate cost-efficacy analysis. Pediatr Hematol Oncol. 2014 Nov;31(8):687–702. doi: 10.3109/08880018.2014.930768
   PubMed Web of Science ®Google Scholar
• Cooper N, Kruse A, Kruse C, et al. Immune thrombocytopenia (ITP) world impact survey (I-WISh): Impact of ITP on health-related quality of life. Am J Hematol. 2021 Feb 1;96(2):199–207. doi: 10.1002/ajh.26036
   PubMed Web of Science ®Google Scholar
• Lassandro G, VV P, Barone A, et al. Fatigue perception in a cohort of children with chronic immune thrombocytopenia and their caregivers using the PedsQL MFS: real-life multicenter experience of the Italian Association of Pediatric Hematology and Oncology (AIEOP). Pediatr Blood Cancer. 2021;68(3):e28840. doi: 10.1002/pbc.28840
   PubMed Web of Science ®Google Scholar